John Stuelpnagel – one of Illumina‘s cofounders – has never had his genome sequenced.
“I didn’t feel the need,” Stuelpnagel said.
It’s not because of the cost, nor the fear he’s got some genetic disorder. It’s not even because he believes it’s an unnecessary move for a healthy man:
“It’s just that sequencing isn’t good enough today for many of the applications we’re looking at for future clinical use,” he said.
Image: http://medcitynews.com
